IGI Labs (IG) Tops Q3 EPS by 5c; Will No Longer be IGI Labs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- Intel shares fall as competitor reports record results
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
IGI Laboratories, Inc. Announces Name Change To Teligent, Inc.
October 22, 2015 4:07 PM EDTBUENA, N.J., Oct. 22, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey-based specialty generic pharmaceutical company, announced that it will adopt Teligent, Inc. as its new name and will begin trading under a new symbol TLGT after ringing the NASDAQ Opening Bell on October 26, 2015.
''Our new name captures the energy and passion that our people feel about our future,'' said Jason Grenfell-Gardner, the Company's President and Chief Executive Officer. ''We are... More
IGI Laboratories Announces Third Quarter 2015 Results
October 22, 2015 4:05 PM EDTBUENA, N.J., Oct. 22, 2015 /PRNewswire/ --Â IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey-based specialty generic pharmaceutical company, announced its financial results for the third quarter ended September 30, 2015.
Third Quarter 2015 Highlights
Total revenues of $11.6 million in the third quarter of 2015, an increase of 74% over the same quarter in 2014 Total net revenues generated from the sale of IGI label generic topical pharmaceutical products for the third quarters of 2015 and 2014 of $8.7 million and $3.0... More


